The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer
20 minutes
Posted Feb 18, 2022 at 10:52 pm.
0:00
20:49
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Jonathan Rosenberg describes the results of this positive randomised trial.
Previous
Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer
Next
Episode 158: ASCO GU 2022 PROpel Phase III olaparib and abiraterone in renal cancer
← See all 501 episodes of The Uromigos